|
CLNS1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.621300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.351700E-04 |
| Normal-vs-Stage2 |
2.223900E-02 |
| Normal-vs-Stage3 |
5.651800E-02 |
| Normal-vs-Stage4 |
5.360400E-03 |
| Stage1-vs-Stage2 |
8.872400E-01 |
| Stage1-vs-Stage3 |
2.457400E-01 |
| Stage1-vs-Stage4 |
6.342200E-01 |
| Stage2-vs-Stage3 |
5.115600E-01 |
| Stage2-vs-Stage4 |
6.567200E-01 |
| Stage3-vs-Stage4 |
2.233200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.579700E-04 |
| Normal-vs-AfricanAmerican |
1.312240E-01 |
| Normal-vs-Asian |
3.215800E-01 |
| Caucasian-vs-AfricanAmerican |
2.521200E-01 |
| Caucasian-vs-Asian |
7.878600E-01 |
| AfricanAmerican-vs-Asian |
8.433400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.750100E-04 |
| Normal-vs-Female |
9.017900E-03 |
| Male-vs-Female |
3.064200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.539800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.143520E-03 |
| Normal-vs-Age(61-80Yrs) |
4.839200E-04 |
| Normal-vs-Age(81-100Yrs) |
8.149800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.631400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.023400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.985900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.944000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.028300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.862300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.010400E-02 |
| Normal-vs-Grade 2 |
2.45209999999441E-05 |
| Normal-vs-Grade 3 |
4.373500E-02 |
| Normal-vs-Grade 4 |
3.026200E-02 |
| Grade 1-vs-Grade 2 |
7.773200E-01 |
| Grade 1-vs-Grade 3 |
4.307200E-01 |
| Grade 1-vs-Grade 4 |
9.850200E-01 |
| Grade 2-vs-Grade 3 |
7.360300E-03 |
| Grade 2-vs-Grade 4 |
7.785800E-01 |
| Grade 3-vs-Grade 4 |
3.097000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.0245999999986E-05 |
| Normal-vs-ccB subtype |
8.815600E-03 |
| ccA subtype-vs-ccB subtype |
3.180200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.358030E-03 |
| Normal-vs-N1 |
6.091800E-02 |
| N0-vs-N1 |
2.177200E-01 |
|
|
